Antioxidant and cholinergic neuroprotective mechanisms in experimental parkinsonism.
Dajas
Federico
F
Department of Neurochemistry, Clemente Estable Institute, Montevideo, Uruguay. fdajas@iibce.edu.uy
Costa
Gustavo
G
Abin-Carriquiry
J Andrés
JA
Echeverry
Carolina
C
Martínez-Borges
Aníbal
A
Dajas-Bailador
Federico
F
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D018678:Cholinergic Agents / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018384:Oxidative Stress / Q000187:drug effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology*; D051381:Rats; D011978:Receptors, Nicotinic / Q000187:drug effects; D013378:Substantia Nigra / Q000473:pathology / Q000503:physiopathology
D000975:Antioxidants; D018678:Cholinergic Agents; D018696:Neuroprotective Agents; D011978:Receptors, Nicotinic